InvestorsHub Logo
Followers 25
Posts 2057
Boards Moderated 0
Alias Born 12/18/2012

Re: None

Tuesday, 05/01/2018 8:59:07 AM

Tuesday, May 01, 2018 8:59:07 AM

Post# of 7710
"Contrary to AE's assertions in his article 4 cited above, Janssen is not about to divorce Geron. Rather, when asked during Johnson & Johnson's Q1 2018 earnings CC by Geoff Meacham as to its strategy around its pipeline and acquisitions, Johnson & Johnson's EVP and CFO Caruso assured Meacham that its pipeline was strong. In this regard he specifically referenced eight new drug applications for products having billion-dollar potential planned by 2021.

Caruso's response ties in directly with Johnson & Johnson's Q1 2018 pipeline slide (relevant extracts below):"
I like that logic......It won't be long and we will know, but as for now looking for adding opps!
Thank you subslover!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News